Margetuximab FDA approval date

The FDA approved Margetuximab (MGAH22) on 16 Dec 2020.

FDA approval date
16 Dec 2020

Drug identity checked against registry records

Also recorded as MGAH22; Margenza®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-12-16DayMargetuximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761150", "applicant_as_listed_by_fda": "TERSERA THERAPEUTICS LLC", "brand_names": ["MARGENZA"], "active_ingredients": ["MARGETUXIMAB-CMKB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201216", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026